Previous studies have shown that abnormal cellular morphology is present in the ventricular septum of patients with asymmetric septal hypertrophy (ASH). The present study was undertaken to determine whether these morphologic abnormalities are limited to the ventricular septum of patients with ASH or are more diffusely distributed throughout the heart, and whether different patterns of distribution of the cellular abnormalities exist in patients with and patients without left ventricular outflow obstruction. Myocardium was obtained at operation or necropsy from 22 patients, including 14 with obstructive and eight with nonobstructive ASH, and studied by both light and electron microscopy. Many hypertrophied, bizarrely shaped, and abnormally arranged cardiac muscle cells, presumably a morphologic manifestation of the genetically transmitted myocardial defect in ASH, were present in the ventricular septum of all patients. In patients with obstructive ASH, these abnormalities were either absent or rarely found in muscle from the left and right ventricular free walls. This observation suggests that functional limitation in these patients is due largely to left ventricular outflow obstruction. In contrast, numerous disorganized cells were extensively distributed in the left and right ventricular feee walls from seven of eight symptomatic patients with nonobstructive ASH, suggesting that these abnormalities probably contribute importantly to functional impairment in such patients.
nonobstructive ASH, two studies were undertaken. The first study, which forms the basis of this communication, describes the distribution of morphologic abnormalities in the heart by light and electron microscopy. The second study13 describes the distribution of wall thickening as determined by echocardiography and by examination of necropsy specimens. Methods
Patient Selection
The morphologic studies reported in this communication were made on myocardium obtained from 22 patients with ASH. The diagnosis of ASH (i.e., the ratio of the thickness of the ventricular septum to that of the posterobasal left ventricular wall is greater than 1.3) was established in all 22 patients by echocardiography,' necropsy examination, or both. Patients were selected for operation (left ventricular myotomy-myectomy) if they had cardiac symptoms sufficient to produce significant functional limitation (New York Heart Association functional classes 3 or 4) and did not respond adequately to propranolol.
Clinical and hemodynamic data from the patients (12 men and ten women; aged 8 to 67 years) are summarized in table 1 . Measurements of the peak systolic pressure gradient between left ventricle and a systemic artery were obtained in all patients under basal conditions and during provocative interventions (Valsalva maneuver or administration of isoproterenol). Patients were divided into three groups on the basis of the magnitude of the gradient: 1) Obstructed group: any gradient present under basal conditions. This group includes 12 patients with gradients of 65 to 162 mm Hg under basal conditions; 2) Provocable obstruction group: no basal gradient but provocable gradients greater than 30 mm Hg. This group includes two patients who had no gradients under basal conditions but developed gradients greater than 30 mm Hg after provocative maneuvers; 3) Nonobstructed group: no pressure gradient under basal conditions and a provocable peak gradient of less than 30 mm Hg. This group includes eight patients. None of the patients without obstruction had had clinical evidence of obstruction prior to the time of cardiac catheterization (i.e., murmurs louder than grade II were not described and carotid tracings did not demonstrate the typical bisferious contour characteristic of most patients with obstruction). Mitral regurgitation was demonstrated by angiocardiogram in seven patients (severe in patient #18, Table 1 Clinical and Hernodynamic Data in 22 The sites from which myocardial tissues were obtained included: the cephalad portion of the left side of the ventricular septum (12 patients); the cephalad portion of the right side of the ventricular septum (two patients); the left ventricular apex (13 patients); the left ventricular posterior wall, about halfway between the left ventricular apex and the atrioventricular groove (12 patients), and the right ventricular anterior wall, in the area of the outflow tract (seven patients).
In patients undergoing left ventricular myotomymyectomy, tissue (about 10 x 10 x 15 mm) was resected from the ventricular septum after 20 to 40 min of cardiopulmonary bypass and after a period of 10 to 12 min of cardiac arrest. During the latter period the aorta was clamped, the heart was cooled to approximately 30°C, and the coronary arteries were not perfused.
Biopsies from the left and right ventricular free walls were obtained after 2 to 5 min of cardiopulmonary bypass but before institution of cardiac arrest. The morphology of cardiac muscle cells in the ventricular free walls differed distinctly in patients with obstruction compared to those without obstruction (table 2) .
ASII with obstruction
In the 12 patients having ASH and left ventricular outflow obstruction, the vast majority of muscle cells fig. 12 ) and increased amounts of Z band-like material at points of attachment of myofibrils to intercellular junctions (intercalated discs). These alterations in Z band structure were of the type considered suggestive of the formation of new sarcomeres. 16 Mitochondrial damage was present in 14 patients and consisted of swelling of mitochondria and disruption of cristae. These abnormalities were more marked in the ventricular septum than in the left ventricular free walls in 11 of the 14 patients, and may have been due to the cardiac arrest under hypothermic and hypoxic conditions.17
Markedly convoluted intercellular junctions (intercalated discs) were a consistent finding in biopsies from all 15 patients. Side-to-side intercellular junctions were present instead of, or in addition to, the more usual end-to-end junctions of muscle cells in seven patients. These side-to-side junctions were usually seen in muscle cells from the ventricular septum in areas of myofibrillar disarray. Areas of separation of the plasma membranes of the undifferentiated segments of intercellular junctions were present in 12 patients ( fig. 13 ). These abnormalities, which resemble those described in other forms of cardiac hypertrophy,18 were more marked in the left and right ventricular walls than in the ventricular septum in 11 of the 12 patients.
In 11 of the 15 patients, all glycogen granules in cardiac muscle cells were in the usual monoparticulate f-form (diameter 225 to 375 A); in the other four patients, some glycogen particles were in the form of large rosettes (o-glycogen) with diameters of 1300 to 2400 A. '5 Dilatation of the transverse tubular system was present in 11 of the 15 patients and was most prominent in the left ventricular wall in seven patients ( fig. 14) . The sarcoplasmic reticulum was normal in hypertrophied cardiac muscle cells from all patients. A few markedly enlarged nuclei with bizarre convolutions of the nuclear membrane were found in biopsies from all patients and were most common in the ventricular septum. Ribosomes were present in increased numbers in most cells from both the ventricular septum and ventricular free walls, and were usually free in perinuclear areas, between myofibrils and near intercellular junctions as well as attached to the membranes of the sarcoplasmic reticulum. Lipofuscin Circotlatiotn, Xolmne 50, Septenmber 1974 arranged are invariably present in the ventricular septum of patients with ASH and left ventricular outflow tract obstruction. The observations in this communication further demonstrate that these cells also are found in the ventricular septum of patients without obstruction. The occurrence of these cells in patients with ASH and no present or previous evidence of outflow obstruction suggests that high ventricular pressure is not the primary mechanism responsible for their unusual morphologic features or their increased size. Moreover, cells with these characteristics are rarely found in patients with cardiac hypertrophy from causes other than ASH. For example, we have observed foci of bizarrely shaped and abnormally arranged cardiac muscle cells in some patients with congenital heart diseases associated with right ventricular outflow tract obstruction8 (and unpublished observations), but have not observed these cells in patients with congestive cardiomyopathies or in patients with left ventricular hypertrophy due to aortic valvular disease. Thus, it appears reasonable to assume that these hypertrophied, bizarrely shaped, 21 Thus, the precise significance of myofibrillar and myofilament disarray in cardiac muscle cells of patients with ASH is presently unclear. In addition, we observed small muscle bundles (com-posed of hypertrophied, but otherwise normal cells) coursing in a disorderly fashion through larger, normally arranged bundles. These bundles, although distinctive in appearance, were an inconsistent and uncommon feature of the hearts studied; the relation of these muscle bundles to the genetically transmitted myocardial defect in ASH is uncertain.
The bizarrely shaped and abnormally arranged cardiac muscle cells present in patients with ASH were greatly hypertrophied, having transverse diameters ranging from 10-70 ,u (average of 28 p). Cells present in the left ventricular free wall of patients with obstructive ASH or severe aortic valvular stenosis, however, also had transverse diameters within the same range. Although these data suggest that the degree of hypertrophy of the muscle cells is the same in ASH and in fixed left ventricular outflow obstruction, we do not believe that this is actually the case. We consider that the measurement of transverse diameter is a poor index of cell size when cells are stellate shaped rather than cylindrical. Indeed, we had the distinct impression that the area (in contrast to the transverse diameter) of the bizarrely shaped cells characteristic of ASH was considerably greater than that of the hypertrophied cells present in patients with fixed left ventricular outflow obstruction.
The biopsy technique employed in this study yielded a relatively small amount of tissue and thus the possibility of a sampling error must be considered. Indeed, other investigators have shown that the abnormal muscle cells in patients with ASH are irregularly distributed within the heart5 22 and may be found predominantly in the middle layer of the ventricular septum and ventricular free walls. 23 The morphologic characteristics of the cardiac muscle cells from tissue removed at operation in this study were, however, remarkably consistent within each of the two groups of patients (obstructive and nonobstructive ASH). More importantly, the morphologic findings in the necropsy specimens, in which multiple full thickness blocks from different areas of the ventricular walls were examined, were similar to those in the operative biopsies. Thus, it appears unlikely that the biopsy data were significantly influenced by sampling error.
In conclusion, our observations indicate that hypertrophied, bizarrely shaped, and disorganized cardiac muscle cells, presumably a morphologic manifestation of the myocardial defect in ASH, are invariably present in the ventricular septum of patients with nonobstructive and with obstructive ASH. These abnormal cells involve the ventricular free walls extensively in symptomatic patients with nonobstructive ASH and probably are responsible for functional impairment. In symptomatic patients with obstructive ASH,
